期刊文献+

偏头痛的临床、脑血流及影像学研究 被引量:2

Study on the clinic,cerebral blood flow and MRI of migraine
下载PDF
导出
摘要 目的 探讨偏头痛与脑白质变性的关系。方法  75例偏头痛患者的临床表现、分型、脑血流及头颅CT或 MRI检测结果进行回顾分析。结果  75例偏头痛患者中 6 2例 TCD检查脑血流速度增加或降低各占 5 0 %。75例中有 4 8例做头颅 MRI检查 ,其中 18例脑白质有多灶性小圆点状长 T1 长 T2 改变。结论 偏头痛患者 MRI出现脑白质变性可能是偏头痛的一种新的特殊类型或者是伴有皮质下脑梗死或白质脑病的常染色体显性遗传性脑动脉病的早期改变。 Objective To explore the relationship between the migraine and leukoencephalopathy. Methods A retropspective study of 75 cases of migraine. Results There were 62 cases showed cerebral blood flow speed increasing or reducing in the 75 cases with migraine. There were long T 1 and long T 2 changes in cerebral white matter of 18 cases from 48 cases having brain MRI of 75 cases migraine. Conclusion The cerebral white matter changes in migraine cases on MRI can be a new special type or early stage change of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL).
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2003年第5期440-441,共2页 Journal of Apoplexy and Nervous Diseases
关键词 偏头痛 脑血流 影像学 头颅MRI检查 分型 Migraine Leukoencephalopathy
  • 相关文献

参考文献2

二级参考文献18

  • 1何庆根,车正兰,谷颖.450例头晕患者的脑动脉血流分析[J].中国超声医学杂志,1996,12(7):31-33. 被引量:7
  • 2匡培根.中华内科学[M].北京:人民卫生出版社,1999.3974.
  • 3Bousser MG, Tournier-Lasserve E. Summary of the proceedings of the First International Workshop on CADASIL. Paris, May 19-21,1993. Stroke, 1994, 25(3): 704-707.
  • 4Sabbadini G, Francia A, Caiandriello L, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Clinical, neuroimaging, pathological and genetic study of a large Italian family. Brain, 1995, 118 ( Pt 1)207-215.
  • 5Joutel A. Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.Nature, 1996, 383(6602): 707-710.
  • 6Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet,1997, 350(9090): 1511-1515.
  • 7Wang T, Sharma S, Fox N, et al. Description of a simple test for CADASIL disease and determination of mutation fiequencies in sporadic ischaemic stroke and dementia patients. J Neurol Neurosurg Psychiatry, 2000,69(5 ) :652-654.
  • 8Hassan A, Markus HS. Genetics and ischaemic stroke. Brain, 2000,123 ( Pt 9)1784-1812.
  • 9Desmond DW, Moroney JT, Lynch T, et al. CADASIL in a North American family: clinical, pathologic, and radiologic findings. Neurology, 1998, 51(3): 844-849.
  • 10Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet,1995, 346(8980): 934-939.

共引文献9

同被引文献27

  • 1Olesen J. Classification and diagnosis criteria for headache disorder, cranal neuralgias and facial pain [J]. Cephalagia,1988,8:71 ~ 73.
  • 2Beckett BE. Headache disorders[A]. In: Dipiro JT, Talbert RL, Yee GC, et al. Pharmacotherapy: A, Pathophysiologic Approach[M]. 3rd ed. Stamford. CT: Appleton & Lange: 1997.1279 ~ 1291.
  • 3Moskowitz MA. Basic mechanisms in vascular headache[J].Nenrol Chin, 1990,8:801 ~ 815.
  • 4Weleh KMA, D' Andrea G, Tepiey N, et al. The concept of migraine as a state of central neuronal hyperecitability [J].Neurol Clin, 1990,8:817 ~ 828.
  • 5Silberstein SD.The pharmacology of rgota-mine and mine and dihydroergotamine[J]. Headache, 1997,37 :s15 ~ s25.
  • 6罗新明.神经病学[M].第4版.北京:人民卫生出版社,2001.242~245.
  • 7Lipton RB, Stewort WF, Von Korff M. Burden of migraine:societal costs and therapeutic opporturnities[J]. Neurology,1997,48(suppl 3) :S4~ 9.
  • 8Capobianco DJ, Cheshire WP, Campbell JK. An overview of the diagnosis and pharmacologic treatment of migraine[J].Mayo Clin Proc, 1996,71:1055 ~ 1066.
  • 9Silberetein SD, Saper JR. Migraine: diagnosis and treatment[A]. In: Dalessio DJ, Silberstein SD, eds. Wolffs Headache and Other Head Pain[M] .6 th ed. New York,NY:Oxford University Press: 1993.96 ~ 170.
  • 10Alldredge BK.Headache[A].In:young LY, Koda-Kimble MA, eds. Applied Therapeutics: The Clinical Use of Drugs[M]. 6th ed. Vancouver, WA: Applied Therapeutics, Inc:1995.50.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部